Comparison of agar dilution, microdilution, Etest and disc diffusion to test the activity of trovafloxacin against Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 5, 1999, Pages 707-709

  Kelly, Linda M ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTIBIOTIC AGENT; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFUSION; DILUTION; INTERMETHOD COMPARISON; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0032946582     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.5.707     Document Type: Article

References (10)

1. Eliopoulos, G. M., Klimm, K., Eliopoulos, C. T., Ferraro, M. J. & Moellering, R. C. (1993). In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of Gram-positive bacteria. Journal of Antimicrobial Chemotherapy 37, 366-70.
2. Pankuch, G. A., Jacobs, M. R. & Appelbaum, P. C. (1995). Activity of CP 99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci. Journal of Antimicrobial Chemotherapy 35, 230-2.
3. Visalli, M. A., Bajaksouzian, S., Jacobs, M. R. & Appelbaum, P. C. (1997). Comparative activities of trovafloxacin, alone and in combination with other agents, against Gram-negative nonfermentative rods. Antimicrobial Agents and Chemotherapy 41, 1475-81.
4. Fass, R. J., Barnishan, J., Solomon, M. C. & Ayers, L. W. (1996). In vitro activities of quinolones, β-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative Gram-negative bacilli. Antimicrobial Agents and Chemotherapy 40, 1412-18.
5. National Committee for Clinical Laboratory Standards. (1998). Performance Standards for Antimicrobial Susceptibility Testing -Eighth Informational Supplement: Approved Standard M100 S8. NCCLS, Wayne, PA.
6. Jones, R. N. (1994). Preliminary interpretive criteria for in vitro susceptibility testing of CP-99,219 by dilution and disc diffusion methods. Diagnostic Microbiology and Infectious Disease 20, 167-70.
7. National Committee for Clinical Laboratory Standards. (1996). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Wayne, PA.
8. Dembry, L. M., Farrel, P. A., Orcutt, D. R., Gerrity, L. A. & Andriole, V. T. (1997). In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest. Journal of Antimicrobial Chemotherapy 39, Suppl. B, 35-42.
9. Jones, R. N., Erwin, M. E. & Croco, J. L. (1996). Critical appraisal of Etest for the detection of fluoroquinolone resistance. Journal of Antimicrobial Chemotherapy 38, 21-5.
10. National Committee for Clinical Laboratory Standards. (1996). Performance Standards for Antimicrobial Disk Susceptibility Tests -Sixth Edition: Approved Standard M2-A6. NCCLS, Wayne, PA.